Showing 741 - 760 results of 1,765 for search '(( 5 ((wt decrease) OR (nn decrease)) ) OR ( 10 ((peer decrease) OR (a decrease)) ))', query time: 0.16s Refine Results
  1. 741
  2. 742
  3. 743
  4. 744
  5. 745
  6. 746
  7. 747
  8. 748
  9. 749
  10. 750
  11. 751
  12. 752
  13. 753
  14. 754
  15. 755
  16. 756

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  17. 757
  18. 758
  19. 759
  20. 760